文献速递外周动脉疾病

在ELEGANCE注册研究中实施增加临床研究多样性的方法

Implementing methods in the ELEGANCE registry to increase diversity in clinical research.
PubMed 文献 · J Vasc Surg · 2023-09-22

ELEGANCE是一项全球性、前瞻性、多中心、上市后注册研究,旨在纳入至少40%女性和40%代表性不足少数族裔(URM)的接受药物洗脱装置治疗的外周动脉疾病(PAD)患者。目前39个中心共纳入750例患者(951处病变),女性占43.2%,URM占47.3%;不同性别间Rutherford分级分布不同(P=0.019),不同种族/族裔组间治疗指征(P=0.003)和新生狭窄比例(P<0.001)及平均病变长度(P=0.008)存在差异。

要点

  • ELEGANCE注册研究采用策略提高女性和URM入组,目前女性占43.2%、URM占47.3%。
  • 不同性别间Rutherford分级分布不同(P=0.019)。
  • 不同种族/族裔组间治疗指征(P=0.003)、新生狭窄比例(P<0.001)和平均病变长度(P=0.008)存在差异。

核心结论

  • ELEGANCE注册数据分析显示,不同性别和种族/族裔间的基线疾病特征存在差异,这些差异可能源于诊断时间、未充分管理的合并症负担和就医可及性等其他潜在因素。

研究设计与样本

  • ELEGANCE是一项全球性、前瞻性、多中心、上市后注册研究,旨在纳入至少40%女性和40%URM的接受药物洗脱装置治疗的PAD患者。

主要发现

  • 目前39个中心共纳入750例患者(951处病变),女性324例(43.2%),URM 350例(47.3%),其中黑人21.6%、亚裔11.2%、西班牙裔/拉丁裔8.5%、其他5.3%。
  • 不同性别间Rutherford分级分布不同(P=0.019)。
  • 不同种族/族裔组间治疗指征不同(P=0.003)。
  • 慢性肢体威胁性缺血在黑人(38.3%)和西班牙裔/拉丁裔(28.1%)患者中高于非西班牙裔白人(21.8%)和亚裔患者(21.4%)。
  • 新生狭窄在亚裔患者中较高(92.3%),黑人、非西班牙裔白人和西班牙裔/拉丁裔患者分别为72.2%、68.7%和77.8%(P<0.001);平均病变长度黑人患者最长(162.7 mm),非西班牙裔白人135.2 mm、亚裔134.8 mm、西班牙裔/拉丁裔128.1 mm(P=0.008)。

关键数值与推荐

  • 纳入标准为年龄≥18岁且接受任何市售的波士顿科学公司(Boston Scientific Corporation)用于外周血管病变的药物洗脱装置治疗;排除标准为预期寿命<1年。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Women and underrepresented minorities (URMs) who are at an increased risk of presenting with severe peripheral artery disease (PAD) and have different responses to treatment compared with non-Hispanic White males yet are underrepresented in PAD research. METHODS: ELEGANCE is a global, prospective, multi-center, post-market registry of PAD patients treated with drug-eluting device that aims to enroll at least 40% women and 40% URMs. The study design incorporates strategies to increase enrollment of women and URMs. Inclusion criteria are age ≥18 years and treatment with any commercially available Boston Scientific Corporation drug-eluting device marketed for peripheral vasculature lesions; exclusion criterion is life expectancy <1 year. RESULTS: Of 750 patients currently enrolled (951 lesions) across 39 sites, 324 (43.2%) are female and 350 (47.3%) are URMs (21.6% Black, 11.2% Asian, 8.5% Hispanic/Latino, and 5.3% other). Rutherford classification is distributed differently between sexes (P = .019). Treatment indication differs among race/ethnicity groups (P = .003). Chronic limb-threatening ischemia was higher for Black (38.3%) and Hispanic/Latino (28.1%) patients compared with non-Hispanic White (21.8%) and Asian patients (21.4%). De-novo stenosis was higher in Asian patients (92.3%) compared with Black, non-Hispanic White, and Hispanic/Latino patients (72.2%, 68.7%, and 77.8%, respectively; P < .001). Mean lesion length was longest for Black patients (162.7 mm), then non-Hispanic White (135.2 mm), Asian (134.8 mm), and Hispanic/Latino patients (128.1 mm; P = .008). CONCLUSIONS: Analyses of data from the ELEGANCE registry show that differences exist in baseline disease characteristics by sex and race/ethnicity; these may be the result of other underlying factors, including time to diagnosis, burden of undermanaged comorbidities, and access to care.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Secemsky EA, Giri J, Brodmann M, et al. Implementing methods in the ELEGANCE registry to increase diversity in clinical research. J Vasc Surg. 2023. PMID: 37742734. doi:10.1016/j.jvs.2023.08.131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。